Survival Benefit of Gemcitabine/Docetaxel Therapy The gem/doce group showed significantly better outcomes, with progression-free, cancer-free, and cancer-specific survival rates 2.6, 2.0, and 3.7 ...

Gemcitabine (TAR-200) is under development for the treatment of upper tract urothelial carcinomas including non-muscle invasive bladder cancer (NMIBC), muscle-invasive transitional cell carcinoma of ...

The revenue for Gemcitabine is expected to reach an annual total of $489 mn by 2034 in the US based off GlobalData’s Expiry Model. The drug’s revenue forecasts along with estimated costs are used to ...

You have gemcitabine and nab-paclitaxel as cycles of treatment. This means that you have the treatment and then a rest to allow your body to recover. Each cycle of treatment lasts 28 days (4 weeks).

Prior to induction BCG, the gemcitabine-docetaxel group had a significantly higher proportion of patients with Ta/Tis (noninvasive) tumors compared with the BCG group (68.8% vs 52.2%), whereas the ...

WASHINGTON, DC—Sequential intravesical gemcitabine-docetaxel (Gem-Doce) for treatment-naïve high-risk nonmuscle-invasive bladder cancer (HR-NMIBC) achieves oncologic outcomes comparable to ...

Intra-arterial administration of gemcitabine conferred a median PFS benefit of 8 months when compared with standard of care for patients with locally advanced pancreatic cancer, according to ...

The statistics also showed that this progression-free survival was superior with NALIRIFOX over nab-paclitaxel plus gemcitabine. There was no statistically significant difference in response rate, ...

Gemcitabine chemotherapy is used for advanced cancers of the breast, lungs, ovaries, and pancreas. Learn about delivery, side effects, effectiveness, and more.

Yes. The randomized phase 3 APACT trial was a well-designed adjuvant trial that evaluated the addition of nab-paclitaxel (Abraxane, Celgene) to gemcitabine — the combination was planned based ...

Gemcitabine belongs to pyrimidine analogs, which require stepwise phosphorylation to the respective triphosphate metabolites to exert their pharmacological activity: gemcitabine is phosphorylated to ...